常用剂量氟苯尼考在罗非鱼肝脏和肾脏中的消除规律及组织学影响Elimination Pattern and Histological Effect of Usual Dosage of Florfenicol in Liver and Kidney of Tilapia(Oreochromis niloticus)
罗理,王伟利,姜兰,谭爱萍,邓玉婷,赵飞
摘要(Abstract):
在水温28℃条件下,以12 mg/kg剂量对罗非鱼单次口服给药,采用HPLC方法测定不同时间实验鱼肝脏和肾脏中的药物水平,分析氟苯尼考在罗非鱼肝、肾组织的吸收及消除规律。结果显示,肝脏和肾脏中的药动学参数均符合药动学一室模型,肝脏的药物消除速度快于肾脏,消除半衰期T1/2β分别为4.89 h和15.93 h;药物在肝脏的Tmax为5.43 h,吸收峰值为4.84μg/g;59 h后肝、肾组织中的药物含量均低于0.8μg/g。取12 mg/kg剂量连续给药7 d的实验鱼肝、肾组织,进行组织学观察,结果显示,给药组罗非鱼的肝、肾组织均未出现病理性变化。此外,氟苯尼考对6株罗非鱼常见病原菌的体外抑菌实验中,最小抑菌浓度(MIC)均≤4 mg/L,表明常用剂量氟苯尼考在罗非鱼体内消除快、残留少且不造成组织损伤,对常见病原菌具有良好的抑菌效果。
关键词(KeyWords): 罗非鱼;氟苯尼考;消除半衰期;一室模型;病理组织学变化;最小抑菌浓度
基金项目(Foundation): 公益性行业(农业)科研专项(201203085);; 广东省科技计划项目(2011B020307001)
作者(Author): 罗理,王伟利,姜兰,谭爱萍,邓玉婷,赵飞
参考文献(References):
- [1]Cannon M,Harford S,Davies J.A comparative study on the inhibitory actions of chlormphenicol,thiamphenicol and some fluorinated derivatives[J].Antimicrob Chemotherob Chemotherapy,1990,26(3):307-317.
- [2]Fukui H,Fujihara Y,Kano T.In vitro and invo antebacterial activities of florfenicol,a new fluorinated analog of thiamphenicol,against fish pathogens[J].Fish Pathology,1987,22(4):201-220.
- [3]McGinnis A,Gaunt P,Santucci T,et al.Simmons R,Endris R.In vitro evaluation of the susceptibility of Edwardsiella ictaluri,etiological agent of enteric septicemia in channel catfish,Ictalurus punctatus(Rafinesque),to florfenicol[J].Vet Diagn Invest,2003,15(6):576-579.
- [4]Michel C,Kerouault B,Martin C.Chlormphenicol and florfenicol susceptibility of fish-pathogenic bacteria isolated in France:comparison of minimum inhibitory concentration,using recommended provisory standards for fish bacteria[J].Journal of applied microbiology,2003,95(5):1008-1015.
- [5]王绍云,李雪梅.喹诺酮类药物在鱼体内的药动学及残留研究概况[J].水利渔业,2006,26(5):110-113.
- [6]湛嘉,李佐卿,康继韬,等.影响水产动物药代动力学的因素[J].中国兽药杂志,2003,37(12):38-41.
- [7]Feng J B,Jia X P.Single dose pharmacokinetic study of flofenicol in tilapia(Oreochromis niloticus×O.aureus)held in freshwater at 22℃[J].Aquaculture,2009,289(1-2):129-133.
- [8]Xie L L,Wu Z X,Chen X X,et al.Pharmacokinetics of florfenicol and its metabolite,florfenicol amine,in rice field eel(Monopterus albus)after a single-dose intramuscular or oral administration[J].Journal of veterinary pharmacology and therapeutics,2012,36(3),229–235.
- [9]Bowser P R,Kosoff R E,Chen C Y,et al.Florfenicol residues in nile tilapia after 10-d oral dosing in feed:effect of fish size[J].Journal of aquatic animal health,2009,21(1):14-17.
- [10]余培建,翁祖桐,樊海平,等.氟苯尼考在欧洲鳗鲡体内的药物代谢动力学的研究[J].福建水产,2005(4):52-57.
- [11]刘永涛,艾晓辉,杨红,等.氟苯尼考及其代谢物氟苯尼考胺在斑点叉尾体内的残留消除规律[J].中国水产科学,2007,14(6):1011-1016.
- [12]Horsberg TE,Martinsen B,Varma KJ.The disposition of 14Cflorfenicol in Atlantic salmon(Salmo salar)[J].Aquaculture,1994,122(2-3):97-106.
- [13]杨桂香,邓国东,邹明,等.氟砜霉素的急性毒性和亚慢性毒性试验[J].中国兽医学报,2000,20(3):275-278.
- [14]W ill iam s R R,Bell T A,L ightner D V.Shrimp antimicrobial testing:toxicity testing and safety determination for twelve antimicrobials with penaeid shrimp larvae[J].Journal of aquatic animal health,1992,4(4):262-270.
- [15]杨先乐.新编渔药手册[M].北京:中国农业出版社,2005:187-189.
- [16]徐力文,廖昌蓉,刘广锋,等.氟苯尼考对杂色鲍的急性毒性及组织毒理学[J].大连水产学院学报,2005,20(4):295-299.
- [17]陈大健,王加才,张萍,等.氟苯尼考对鲫鱼CYP2E1活性影响的药代动力学评价[J].中国兽医科学,2007,37(3):269-273.
- [18]操继跃,周洪波,卢笑丛,等.氟苯尼考和中草药黄芪淫羊藿合剂对鸡体液免疫反应的影响[J].畜牧兽医学报,2003,34(4):412-416.
- [19]马建云.氟苯尼考对猪的免疫力及部分血液生理生化指标影响的探讨[D].扬州:扬州大学,2006.
- [20]曹海鹏,闫明,杨先乐.氟苯尼考的体外抑菌作用及其对鲫抗嗜水气单胞菌感染的效果[J].渔业现代化,2007,37(4):47-49,53.
- [21]廖昌容,徐力文,陈毕生.氟苯尼考对六种海洋致病弧菌的体外抗菌活性研究[J].水产养殖,2005,26(4):1-4.
- [22]王伟利,罗理,姜兰,等.适温条件下氟苯尼考在罗非鱼体内的药物动力学[J].大连海洋大学学报,2010,25(4):285-288.
- [23]Gaunt P S,Langston C,Wrzesinski C,et al.Multidose pharmacokinetics of orally administered florfenicol in the channel catfish(Ictalurus punctatus)[J/OL].[2013-04-01].Journal of Veterinary Pharmacology and Therapeutics.doi:10.1111/j.1365-2885.2012.01426.x(.Epub ahead of print).http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2885.2012.01426.x/full.
- [24]Gaunt P S,Langston C,Wrzesinski C,et al.Single intravenous and oral dose pharmacokinetics of florfenicol in the channel catfish(Ictalurus punctatus).Journal of Veterinary Pharmacology and Therapeutics.2011,35(5):503-507.